当前位置:首页 - 行情中心 - 鹿得医疗(920278) - 财务分析 - 现金流量表

鹿得医疗

(920278)

  

流通市值:5.65亿  总市值:13.31亿
流通股本:7404.80万   总股本:1.75亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金65,317,203.95422,418,666.16332,050,144.44257,888,364.72
  收到的税费返还9,021,296.4630,016,289.8725,965,083.7919,454,766.64
  收到其他与经营活动有关的现金1,627,238.264,239,324.424,518,541.992,647,792.32
  经营活动现金流入小计75,965,738.67456,674,280.45362,533,770.22279,990,923.68
  购买商品、接受劳务支付的现金48,932,211.49201,098,853.04139,518,490.493,267,454.04
  支付给职工以及为职工支付的现金21,426,364.8174,738,861.2455,855,882.3538,313,224.3
  支付的各项税费1,648,924.929,451,394.697,467,994.696,188,640.1
  支付其他与经营活动有关的现金10,576,612.1918,210,825.4127,433,241.6813,153,970.41
  经营活动现金流出小计82,584,113.41303,499,934.38230,275,609.12150,923,288.85
  经营活动产生的现金流量净额-6,618,374.74153,174,346.07132,258,161.1129,067,634.83
二、投资活动产生的现金流量:
  收回投资收到的现金478,259,218.1801,451,487.66500,301,792.65263,972,755.61
  取得投资收益收到的现金391,903.774,189,043.493,459,815.91435,005.03
  收到的其他与投资活动有关的现金7,336,746.75,109,677.35--
  投资活动现金流入小计485,987,868.57810,750,208.5503,761,608.56264,407,760.64
  购建固定资产、无形资产和其他长期资产支付的现金14,685,729.9143,217,448.4439,316,308.3431,766,477.61
  投资支付的现金427,331,741.75896,806,630580,322,161.07378,033,765.97
  投资活动现金流出小计442,017,471.66940,024,078.44619,638,469.41409,800,243.58
  投资活动产生的现金流量净额43,970,396.91-129,273,869.94-115,876,860.85-145,392,482.94
三、筹资活动产生的现金流量:
  取得借款收到的现金29,500,00054,900,00054,900,00054,900,000
  收到其他与筹资活动有关的现金-17,417.3914,089,173.814,089,173.8
  筹资活动现金流入小计29,500,00054,917,417.3968,989,173.868,989,173.8
  偿还债务支付的现金35,010,00030,790,00030,790,00020,800,000
  分配股利、利润或偿付利息支付的现金133,399.436,015,996.6135,612,877.5518,108,161.21
  支付其他与筹资活动有关的现金150,416.67450,0009,836,996.45227,500
  筹资活动现金流出小计35,293,816.0767,255,996.6176,239,87439,135,661.21
  筹资活动产生的现金流量净额-5,793,816.07-12,338,579.22-7,250,700.229,853,512.59
四、汇率变动对现金及现金等价物的影响-701,590.38-778,854.33730,153.54-562,928.18
五、现金及现金等价物净增加额30,856,615.7210,783,042.589,860,753.5912,965,736.3
  加:期初现金及现金等价物余额139,665,164.67128,882,122.09128,882,122.09128,882,122.09
  期末现金及现金等价物余额170,521,780.39139,665,164.67138,742,875.68141,847,858.39
补充资料:
  净利润-19,220,537-9,817,579.99
  资产减值准备--436,102.41--172,343.83
  固定资产和投资性房地产折旧-6,630,610.24-3,314,452.32
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-6,630,610.24-3,314,452.32
  无形资产摊销-575,036.08-521,065.93
  长期待摊费用摊销-244,509.22-145,731.5
  处置固定资产、无形资产和其他长期资产的损失-3,276.33--
  公允价值变动损失--440,882.65--603,334.93
  财务费用-2,650,452.08-1,106,815.78
  投资损失--2,843,824.45-99,393.91
  递延所得税--1,421.78-168,553.4
  其中:递延所得税资产减少--1,421.78-168,553.4
  存货的减少-4,241,545.78--1,375,423.72
  经营性应收项目的减少-59,383,074.8-68,309,062.65
  经营性应付项目的增加-65,419,290.07-49,590,248.19
  现金的期末余额-139,665,164.67-141,847,858.39
  减:现金的期初余额-128,882,122.09-128,882,122.09
  现金及现金等价物的净增加额-10,783,042.58-12,965,736.3
公告日期2026-04-282026-04-282025-10-292025-08-26
审计意见(境内)标准无保留意见
TOP↑